Chlorambucil serves as a vital treatment for a specific form of chronic lymphocytic leukemia (CLL), a type of cancer affecting white blood cells. Additionally, it is employed in managing non-Hodgkin’s lymphoma (NHL) and Hodgkin’s disease, both of which originate from particular white blood cells designed to combat infections. Classified under the category of alkylating agents, Chlorambucil exerts its therapeutic effect by impeding the growth of cancerous cells within the body.

The blend of trifluridine and tipiracil is employed in the treatment of colon or rectal cancer that has metastasized to other areas of the body, especially in individuals previously treated with other chemotherapy drugs or unable to tolerate them.

The active compound, loteprednol etabonate, in Lotemax Gel reduces the production of inflammation-inducing substances within the eye. Its unique action focuses primarily on the affected ocular tissues, minimizing systemic exposure and side effects. This selective presence not only ensures a reduction in inflammation but also minimizes risks typically associated with broader systemic corticosteroid use.

Sotorasib is prescribed to adults with non-small cell lung cancer (NSCLC) that has metastasized or is inoperable after prior treatments. It belongs to the class of drugs known as KRAS inhibitors, working to disrupt the abnormal protein driving cancer cell multiplication, ultimately slowing or halting cancer spread.